The Journal of Cell Communication and Signaling provides a forum for fundamental and translational research. In particular, it publishes papers discussing intercellular and intracellular signaling pathways that are particularly important to understand how cells interact with each other and with the surrounding environment, and how cellular behavior contributes to pathological states. JCCS encourages the submission of research manuscripts, timely reviews and short commentaries discussing recent publications, key developments and controversies.
Research manuscripts can be published under two different sections :.
In the Pathology and Translational Research Section (Section Editor Andrew Leask) , manuscripts report original research dealing with celllular aspects of normal and pathological signaling and communication, with a particular interest in translational research.
In the Molecular Signaling Section (Section Editor Satoshi Kubota) manuscripts report original signaling research performed at molecular levels with a particular interest in the functions of intracellular and membrane components involved in cell signaling.
The Review Section (Section Editor David Brigstock) is a venue for publication of review articles that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. The Journal is particularly interested in focused and authoratative mini-reviews that will allow the reader to gain a rapid understanding of the material presented. Mini-reviews should not exceed 5000 words, excluding the abstract and bibliography. No more than 80 references should be cited. Inclusion of figures to help summarize the major concepts is encouraged. Authors are requested to contact the Section Editor with a proposed outline of their article before submission so that its suitability for publication in the journal can be assessed.
The ‘At the Forefront of Unforeseen Science’ section (Section Editor Bernard Perbal publishes peer-reviewed articles reporting on groundbreaking discoveries that promise to have an impact on the future of mankind. The manuscripts should be written in the form of a concise analysis and review of exciting advances in any scientific field that will offer novel perspectives that could open new avenues for research and applications
The Bits & Bytes section (Section Editors Andrew Leask and Herman Yeger) provides a forum for the rapid distribution of short commentaries on recent publications and news that are of interest to the scientific community. These commentaries also appear on the Web site of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.

Editor-in-Chief 
Bernard Perbal
GREDEG, Nice, France 
President of the International CCN Society

Managing Editor
Andrew Leask, University of Western Ontario, Ontario, Canada

Section Editors
Pathology and Translational Research
Andrew Leask, University of Western Ontario, Ontario, Canada
Molecular Signaling
Satoshi Kubota, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Reviews
Dieter P. Reinhardt, McGill University, Montreal, Canada
Bits and Bytes
Andrew Leask, University of Western Ontario, Ontario, Canada

Administrative Assistant 
Annick Perbal 

Editorial Board 
David Abraham, University College London, London, UK
K. Ravi Acharya, University of Bath, Bath, UK
Patrick Auberger, INSERM U1065, Nice, France
Sushanta Banerjee, University of Kansas Medical Center, Kansas City MO, USA
George Bou-Gharios, University of Liverpool, Liverpool, UK
Enrique Brandan, Pontificia Universidad Católica de Chile, Chile
Rolf Brekken, The University of Texas Southwestern Medical Center, Dallas TX, USA
David Brigstock, Children's Research Institute, Columbus OH, USA
Carlo Croce, Ohio State University Medical Center, Columbus OH, USA
Mick Dashwood, Royal Free Hospital, London, UK
Marc Diederich, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Gary Fisher, University of Michigan Mecial School, Ann Arbor MI, USA
Roel Goldschmeding, University Medical Center Utrecht, Utrecht, The Netherlands
Donald Gullberg, University of Bergen, Bergen, Norway
Sandra Irvine, Queen's University Belfast, Belfast, Northern Ireland
Celina Kleer, University of Michigan, Ann Arbor MI, USA
Akira Kudo, Tokyo Institute of Technology, Tokyo, Japan
Paul Lasko, McGill University, Montreal QC, Canada
Lester Lau, University of Illinois, Chicago IL, USA
Jack Lawler, Beth Israel Deaconess Medical Center, Boston MA, USA
Zhiyong Lin, Case Western Reserve University, Cleveland OH, USA 
Kathryn E Meier, Washington State University, Spokane, WA, USA 
Kohei Miyazono, University of Tokyo, Tokyo, Japan
Joanne E. Murphy-Ullrich, University of Alabama, Birmingham AL, USA
Kunimasa Ohta, Kumamoto University, Kumamoto, Japan
Anie Philip, McGill University, Montreal QC, Canada
Lynne-Marie Postovit, University of Alberta, Edmonton AB, Canada
David D. Roberts, National Institutes of Health, Bethesda MD, USA
Katia Scotlandi, Istituti Ortopedici Rizzoli, Bologna, Italy
Peter Siegel, McGill University, Montreal QC, Canada
Ulf Smith, University of Gothenburg, Sweden
Masaharu Takigawa, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Philip C. Trackman, Boston University, Boston MA, USA
Stephen Twigg, Royal Prince Alfred Hospital, Sydney, Australia
Ralf Weiskirchen, Aachen University Hospital, Germany
Denys Wheatley, BioMedES Ltd., Aberdeenshire, UK
Zhaolin Yang, Cold Spring Harbor, New York, USA
Herman Yeger, The Hospital for Sick Children, Toronto, Canada

Advisory Board 
Robert Baxter, University of Sydney, St Leonards, Australia
Edward Calabrese, University of Massachusetts, Amherst MA, USA 
Meenhard Herlyn, The Wistar Institute, Philadelphia PA, USA
Piero Picci, Istituti Rizzoli, Bologna, Italy
Bernard Roizman, University of Chicago, Chicago IL, USA